Lupin Pharmaceuticals Inc. has voluntarily recalled 51,006 bottles of Cefdinir for Oral Suspension USP (250 mg/5 mL), an antibiotic used to treat various bacterial infections. This recall was issued because the bottles were found to have defective containers that lack proper seal integrity. If you have health concerns about this medication, contact your healthcare provider or pharmacist for guidance. You should return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
A lack of seal integrity can expose the medication to air or moisture, which may compromise the drug's stability and make it less effective at treating infections. There are no reports of injuries to date.
You have 2 options:
Quantity affected: 51,006 bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.